In support of this, we observed that DDR2 expression was robustly correlated with 42-gene mesenchymal metabolic signature (28) across TCGA breast cancer samples (R = 0.84, Spearman; Supplementary Fig. S7A). This evidence concerns the gene DDR2 and breast carcinoma.